XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Financial Instruments and Fair Value Measurements (Tables)
6 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents
The following reconciles cash and equivalents and restricted cash reported within the Company's consolidated balance sheets at March 31, 2019 and September 30, 2018 to the total of these amounts shown on the Company's consolidated statements of cash flows:
(Millions of dollars)
March 31, 2019
 
September 30, 2018
Cash and equivalents
$
686

 
$
1,140

Restricted cash
81

 
96

Cash and equivalents and restricted cash
$
767

 
$
1,236